Amicus Therapeutics (FOLD) Updates on Migalastat Phase 3; Top-Line Data Expected in Q314
Tweet Send to a Friend
Amicus Therapeutics (Nasdaq: FOLD) has provided updates and detailed the statistical analysis plan for its second Phase 3 study (Study ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE